13939-70-3 Usage
Uses
Used in Photodynamic Therapy:
8,13-diethyl-3,7,12,17,20-pentamethyl-21H,23H-porphine-2-propionic acid is used as a photosensitizing agent in photodynamic therapy for the treatment of various cancers and diseases. Its unique molecular structure allows it to absorb light at specific wavelengths and generate reactive oxygen species upon light activation, leading to the destruction of targeted cells.
Used in Medical Research:
In the field of medical research, 8,13-diethyl-3,7,12,17,20-pentamethyl-21H,23H-porphine-2-propionic acid serves as a valuable compound for studying the properties and mechanisms of porphyrin-based compounds. Its complex molecular structure provides insights into the development of new therapeutic agents and diagnostic tools for various medical conditions.
Used in Biochemistry:
8,13-diethyl-3,7,12,17,20-pentamethyl-21H,23H-porphine-2-propionic acid is utilized in biochemistry for understanding the role of porphyrins and their derivatives in biological systems. Its unique structure aids in the investigation of molecular interactions, enzymatic activities, and potential applications in the development of new drugs and therapies.
Used in Drug Development:
In the pharmaceutical industry, 8,13-diethyl-3,7,12,17,20-pentamethyl-21H,23H-porphine-2-propionic acid is employed as a starting material or a building block for the synthesis of novel drug candidates. Its versatile molecular structure allows for the design and development of targeted therapies for various diseases, including cancer and other conditions that can benefit from photodynamic therapy.
Check Digit Verification of cas no
The CAS Registry Mumber 13939-70-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,9,3 and 9 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 13939-70:
(7*1)+(6*3)+(5*9)+(4*3)+(3*9)+(2*7)+(1*0)=123
123 % 10 = 3
So 13939-70-3 is a valid CAS Registry Number.
